Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Tumor-Agnostic 3 Gastrointestinal 1

Conditions

Pain, Postoperative 6 Pancreatic Neoplasms 5 Colorectal Neoplasms 4 Rectal Neoplasms 3 Colonic Neoplasms 3 Agnosia 3 Liver Neoplasms 2 Stomach Neoplasms 1 Pain 1 Neuralgia 1 Neoplasms 1 Intestinal Perforation 1 Intestinal Diseases 1 Inflammatory Bowel Diseases 1 Ileus 1 Gastrointestinal Neoplasms 1 Gastrointestinal Diseases 1 Duodenal Neoplasms 1 Diverticulosis, Colonic 1 Diverticulitis, Colonic 1 Diverticulitis 1 Digestive System Diseases 1 Crohn Disease 1 Constipation 1

Interventions

Gemcitabine 69 Fluorouracil 44 pembrolizumab 43 Oxaliplatin 42 Capecitabine 40 Bevacizumab 37 Leucovorin 36 Irinotecan 31 Cisplatin 27 Nivolumab 24 Paclitaxel 21 Cetuximab 21 Panitumumab 20 130-nm albumin-bound paclitaxel 20 Sorafenib 18 Albumin-Bound Paclitaxel 18 Drug Therapy 15 Docetaxel 15 Cyclophosphamide 15 Radiotherapy 14 Blood Specimen Collection 14 IFL protocol 12 atezolizumab 11 Exercise 11 Taxes 10 budigalimab 9 Erlotinib Hydrochloride 9 trametinib 8 Folfox protocol 8 Carboplatin 8

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Neoplasms × Bupivacaine × Gastrointestinal × Clear all

NCT02210260 2016-09-14

PROSP

York Teaching Hospitals NHS Foundation Trust

Phase NA Completed

Gastrointestinal

Neoplasms, Colorectal Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡